Lisata Therapeutics Inc.

Last updated September 27, 2026

Organization details

Legal name
Lisata Therapeutics Inc.
Former names
Caladrius Biosciences, Inc. NeoStem, Inc. Phase III Medical Inc Corniche Group Inc
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
Basking Ridge
Headquarters state / province
New Jersey
Headquarters country
United States
Fiscal year end
December
Ticker symbol
LSTA
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0000320017
EIN
22-2343568
Wikidata ID
Q6994181

Board of directors

Chief executives

David J. Mazzo · Chief Executive Officer
Dates unknown

Board connections

4 of this board's directors also sit on 9 other boards. 9 are in the same sector.

Network of Lisata Therapeutics Inc.'s board connections Aquestive Therapeutics Inc. Aquestive Therapeutics... Gilead Sciences Inc. Gilead Sciences Inc. Jazz Pharmaceuticals plc Jazz Pharmaceuticals p... Korsana Biosciences Inc. Korsana Biosciences In... PepGen Inc. PepGen Inc. Perspective Therapeutics Inc. Perspective Therapeuti... Royalty Pharma plc Royalty Pharma plc Structure Therapeutics Inc. Structure Therapeutics... Xenon Pharmaceuticals Inc. Xenon Pharmaceuticals... Gregory B. Brown Gregory B. Brown Heidi Henson Heidi Henson Mohammad Azab Mohammad Azab Ted W. Love Ted W. Love Lisata Therapeutics Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$0
0 purchases by 0 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Jan 9, 2026 David J. Mazzo Director, Officer (President & CEO) Grant or award +81,000 — —
Jan 9, 2026 Nisco James Officer (SVP, Fin/Treas, Chief Actg Off) Grant or award +15,000 — —
Jan 9, 2026 Imam Tariq Officer (SVP, Bus Dev, General Counsel) Grant or award +15,000 — —
Jan 9, 2026 Buck Kristen K Officer (EVP, R&D and CMO) Grant or award +25,000 — —
Jan 9, 2026 Steven M. Klosk Director Grant or award +30,456 — —
Jan 9, 2026 Heidi Henson Director Grant or award +30,456 — —
Jan 9, 2026 Cynthia Louise Flowers Director Grant or award +30,456 — —
Jan 9, 2026 Gregory B. Brown Director Grant or award +30,456 — —
Jan 9, 2026 Mohammad Azab Director Grant or award +30,456 — —
Jan 9, 2026 David J. Mazzo Director, Officer (President & CEO) Shares withheld for tax −10,503 $1.97 $20,691
Jan 9, 2026 Nisco James Officer (SVP, Fin/Treas, Chief Actg Off) Shares withheld for tax −2,131 $1.97 $4,198
Jan 9, 2026 Imam Tariq Officer (SVP, Bus Dev, General Counsel) Shares withheld for tax −1,401 $1.97 $2,760
Jan 9, 2026 Buck Kristen K Officer (EVP, R&D and CMO) Shares withheld for tax −2,982 $1.97 $5,875
Jan 9, 2026 David J. Mazzo Director, Officer (President & CEO) Shares withheld for tax −10,515 $1.97 $20,715
Jan 9, 2026 Nisco James Officer (SVP, Fin/Treas, Chief Actg Off) Shares withheld for tax −2,131 $1.97 $4,198

Organizations in the same sector, closest in location and size first.

Questions about Lisata Therapeutics Inc.

Who is the CEO of Lisata Therapeutics Inc.?

David J. Mazzo is Lisata Therapeutics Inc.'s Chief Executive Officer.

How many directors are on Lisata Therapeutics Inc.'s board?

Lisata Therapeutics Inc.'s board has 9 directors: Cynthia Louise Flowers, David J. Mazzo, David W. Slack, Erkki Ruoslahti, Gregory B. Brown, Heidi Henson, Mohammad Azab, Steven M. Klosk and Ted W. Love.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="lisata-therapeutics-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.